Delivery Order SPE2DB25D2204-SPE2DB25FTGCJ

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,114.56, is a Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML. The contract has an ultimate completion date of January 13, 2025 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,680.85, is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,628.46, is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a prescription eye medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 13, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,375.24 firm-fixed-price delivery order is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a period of performance through July 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,498.22, is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of May 31, 2024. The contract was awarded on May 30, 2024 and does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.12 firm-fixed-price delivery order is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a specialty ophthalmic medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,685.84, is for the delivery of 5 ml bottles of Difluprednate 0.05% eye drops. The contract is a Firm Fixed Price Delivery Order with a completion date of January 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor, for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML. The $2,877.51 firm fixed-price delivery order has a completion date of March 10, 2023 and was awarded on March 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a ceiling value of $14,663.65. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, which has a maximum value of $999,999,999.00 and runs through...
This federal contract award, valued at $2,210.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Difluprednate 0.05% Eye Drop, 5mL, and has a completion date of May 11, 2023. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued...
  • SPE2DB25D2204
    Indefinite Delivery Contract
  • SPE2DB25D2204-SPE2DB25FTGCJ
    Delivery Order

This federal contract award is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $1,602.05. The award has an ultimate completion date of February 28, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract award reviewed does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 2:42 AM